Plans for the £1 billion expansion of London Cancer Hub, led by Aviva Capital Partners and development manager Socius, have received consent from Sutton Council. The approved scheme will deliver around 1 million sq ft of state-of-the-art laboratory and research space, unlocking the next phase of growth at the London Cancer Hub and strengthening the UK’s science and innovation infrastructure.
Planning approval was granted on World Cancer Day (4 February), underlining the urgency of advancing cancer research and treatment. The development will play a vital role in helping the UK tackle future health challenges by providing critical science infrastructure that supports innovation, attracts investment, and accelerates life-saving discoveries.
